Trialing vs Guía de Linfoma de GELTAMO Utilisation & Stats

Trialing is a platform that helps doctors easily find the most suitable clinical trial for their patients and establish direct contact with the principal investigator. No delays or bureaucracy. We work with reviewed, organized, and categorized data. At Trialing, we don't settle for just showing the features of clinical trials; we go into detail. Thanks to our network of healthcare professionals, we know precisely which hospitals are recruiting. This way, you can choose the most appropriate hospital to refer your patient to. At Trialing, we offer the opportunity to contact the destination center directly: no intermediaries and no delays.
  • Apple App Store
  • Gratuit
  • Médical

Classement dans le store

- -

This mobile app with Interactive Guides in Lymphoma has been developed by the Spanish Research Group specialized in Lymphomas (GELTAMO). These interactive guides have been prepared and reviewed by leading lymphoma experts and are grounded in evidence-based medicine findings, providing a comprehensive set of recommendations for medical professionals to help patients with the best care options. This app must be able to be used in mobile devices by medical professionals in geographic areas without Internet connection and medical centers isolated installations without Internet connection such us nuclear medicine, radiotherapy rooms among others.
  • Apple App Store
  • Gratuit
  • Médical

Classement dans le store

- -

Comparaison des classements Trialing vs. Guía de Linfoma de GELTAMO

Comparez l'évolution du classement de Trialing au cours des 28 derniers jours à celle de Guía de Linfoma de GELTAMO.

Rank

Aucune donnée disponible

Comparaison des classements Trialing et Guía de Linfoma de GELTAMO par pays

Comparez l'évolution du classement de Trialing au cours des 28 derniers jours à celle de Guía de Linfoma de GELTAMO.

Aucune donnée à afficher

Comparez avec n'importe quel site grâce à notre essai gratuit

Démarrer
Trialing VS.
Guía de Linfoma de GELTAMO

janvier 1, 2025